Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. (SHE:300937)

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Pharmaceutical Wholesale - Terminal Pure Sales	2.42B	2.26B	2.36B	2.37B	2.11B
Pharmaceutical Wholesale - Terminal Pure Sales Growth	7.10%	-4.21%	-0.36%	12.34%	29.07%
Pharmaceutical Wholesale - Commercial Distribution	1.51B	1.75B	1.97B	1.54B	1.25B
Pharmaceutical Wholesale - Commercial Distribution Growth	-13.73%	-11.26%	28.05%	23.70%	12.01%
Pharmaceutical Industry	367.53M	232.32M	39.33M	12.68M	12.55M
Pharmaceutical Industry Growth	58.20%	490.67%	210.10%	1.08%	-
Pharmaceutical Retail	117.88M	112.21M	30.31M	19.59M	14.38M
Pharmaceutical Retail Growth	5.05%	270.25%	54.67%	36.25%	-44.66%
health products, technologies and services	33.06M	34.68M	23.54M	23.65M	16.23M
health products, technologies and services Growth	-4.68%	47.34%	-0.48%	45.73%	2.49%
Total	4.45B	4.39B	4.43B	3.97B	3.40B
Total Growth	1.35%	-0.81%	11.62%	16.72%	21.88%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
China	4.45B	4.39B	4.43B	3.97B	3.40B
China Growth	1.35%	-0.81%	11.62%	16.72%	21.88%
Total	4.45B	4.39B	4.43B	3.97B	3.40B
Total Growth	1.35%	-0.81%	11.62%	16.72%	21.88%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 12, 2026

Data Sources Report a data error